The synergistic activity of SBC3 in combination with Ebselen against Escherichia coli infection

Escherichia coli ranks as the number one clinical isolate in the past years in China according to The China Antimicrobial Surveillance Network (CHINET), and its multidrug-resistant (MDR) pathogenic strains account for over 160 million cases of dysentery and one million deaths per year. Here, our wor...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hao, Lu, Qianqian, An, Haoyue, Li, Juntong, Shen, Shuchu, Zheng, Xi, Chen, Wei, Wang, Lu, Li, Jihong, Du, Youqin, Wang, Yueqing, Liu, Xiaowen, Baumann, Marcus, Tacke, Matthias, Zou, Lili, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797518/
https://www.ncbi.nlm.nih.gov/pubmed/36588729
http://dx.doi.org/10.3389/fphar.2022.1080281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797518/
https://www.ncbi.nlm.nih.gov/pubmed/36588729
http://dx.doi.org/10.3389/fphar.2022.1080281

Ejemplares similares